2 terminated. 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Terminated 2 |
Follow Stem Cell Factor: new trials by email Literature Review of Stem Cell Factor trials Research Report on Stem Cell Factor
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Peripheral Stem Cell Transplantation to Prevent Neutropenia in Patients Receiving Chemotherapy for Relapsed or Refractory Non-Hodgkin's Lymphoma epoetin alfa, filgrastim, recombinant flt3 ligand - Lymphoma, Neutropenia | Phase 1 | Terminated | Northwestern University | 3 | 1999-09-01 | 2012-06-01 |
| Biological Therapies Following Peripheral Stem Cell Transplantation in Treating Patients With Non-Hodgkin's Lymphoma, Hodgkin's Disease, or Advanced Breast Cancer aldesleukin, filgrastim, recombinant human stem cell factor - Breast Cancer, Lymphoma | Phase 1 | Terminated | Masonic Cancer Center, University of Minnesota | 1999-05-01 | 2017-11-29 |
Burkitt Lymphoma (2) · Leukemia, Lymphocytic, Chronic, B-Cell (2) · Lymphoma (2) · Lymphoma, B-Cell, Marginal Zone (2) · Lymphoma, Follicular (2) · Lymphoma, Large B-Cell, Diffuse (2) · Lymphoma, Large-Cell, Immunoblastic (2) · Lymphoma, Mantle-Cell (2) · Lymphoma, Non-Hodgkin (2) · Precursor Cell Lymphoblastic Leukemia-Lymphoma (2) · Breast Neoplasms (1) · Hodgkin Disease (1) · Neutropenia (1)
Masonic Cancer Center, University of Minnesota (1) · Northwestern University (1)
United States (1)
Jane N. Winter, MD (1) · Linda J. Burns, MD (1)